The YTHDF proteins shape the brain gene signatures of Alzheimer's disease
Shinya TasakiiD, Denis R. AveyiD, Nicola A. KearnsiD, Chunjiang YuiD, Sashini L De Tissera, Himanshu VyasiD, Lin Cheng, Jishu XuiD, Artemis IatrouiD, Daniel J. Flood, Wenlong LiiD, Lisa Laverne BarnesiD, Katherine L. RothameliD, Aliza P. WingoiD, Thomas S. WingoiD, Nicholas T. SeyfriediD, Chuan HeiD, Philip L. De JageriD, Gene Wei-Ming YeoiD, Chris GaiteriiD, David A. Bennett, Yanling WangiD
Abstract
The gene signatures of Alzheimers Disease (AD) brains reflect an output of a complex interplay of genetic, epigenetic, epi-transcriptomic, and post-transcriptional regulation., yet the dominant factor shaping these signatures remains unclear. To identify the most significant factor that shapes the AD brain signatures, we integrated cellular and molecular features with differential gene expression in in an explainable machine learning framework. Our result indicates that YTHDF proteins, the canonical readers of N6-methyladenosine RNA modification (m6A), are the most influential predictors of the AD brain signatures. We then show that protein modules containing YTHDFs are downregulated in human AD brains, and knocking down and pharmacologically inhibiting YTHDFs in iPSC-derived 2D and 3D neuronal models recapitulate the AD-associated transcriptional signatures. Furthermore, eCLIP-seq analysis revealed that YTHDF proteins influence AD signatures through both m6A-dependent and independent pathways. These results highlight the central role of YTHDF proteins in shaping the gene signatures of AD brains.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional dissection of Alzheimer’s disease brain gene expression signatures in humans and mouse models
Ying‐Wooi Wan, Rami Al-Ouran, … Joshua M Shulman·bioRxiv·Jan 3, 2019
- Alzheimer’s patient brain myeloid cells exhibit enhanced aging and unique transcriptional activation
Karpagam Srinivasan, Brad A. Friedman, … David V. Hansen·Cell ReportsPeer-reviewed·Jun 1, 2020
- Identification and drug-induced reversion of molecular signatures of Alzheimers disease onset and progression in AppNL-G-F, AppNL-F and 3xTg-AD mouse models
Eduardo Pauls, Sergi Bayod, … Patrick Aloy·Genome MedicinePeer-reviewed·Oct 26, 2021
- Early oligodendrocyte dysfunction signature in Alzheimer's disease: Insights from DNA methylomics and transcriptomics
Katherine Fodder, Hannah M. G. Smith, … Conceição Bettencourt·Molecular PsychiatryPeer-reviewed·Jun 18, 2026
- Integrative Epigenomic Landscape of Alzheimer's Disease Brains Reveals Oligodendrocyte Molecular Perturbations Associated with Tau
Stephanie R. Oatman, Joseph S. Reddy, … Nilüfer Ertekin‐Taner·Nature CommunicationsPeer-reviewed·Mar 3, 2026
- YTHDF2 in dentate gyrus is the m6A reader mediating m6A modification in hippocampus-dependent learning and memory
Mengru Zhuang, Xiaoqi Geng, … Sheng‐Jian Ji·Molecular PsychiatryPeer-reviewed·Jan 20, 2023